Advanced search
Companies (1)
Annexin Pharmaceuticals AB (publ) is a Sweden-based biotechnology company. Its main product is ANXV, a human recombinant protein Annexin A5, for emergency treatment of patients with cardiovascular disease with blood vessel damages and inflammation. ANXV h ...
Capitalization | 8 M USD |
---|---|
Change | +7.28% |
1-year price change | +7.69% |
- Stock Market
- Advanced search
- Mikael Dolsten
- Company Profiles